Age-Stratified Real World Outcomes in People with Relapsing Multiple Sclerosis over 50 Years of Age after Switching to Cladribine Tablets from High Efficacy Disease Modifying Therapies
MULTIPLE SCLEROSIS JOURNAL(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要